Fluoroquinolone resistance among Neisseria gonorrhoeae isolates in Hawaii, 1990-2000: Role of foreign importation and increasing endemic spread

Sexually Transmitted Diseases

Volumn 31, Issue 12, 2004, Pages 702-708

  Iverson, Christopher J ^a,c   Wang, Susan A ^a   Lee, Marie V ^b   Ohye, Roy G ^b   Trees, David L ^a   Knapp, Joan S ^a   Effler, Paul V ^b   O'Connor, Norman P ^b   Levine, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HAWAII STATE DEPARTMENT OF HEALTH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ASIAN; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GONORRHEA; HETEROSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEISSERIA GONORRHOEAE; NONHUMAN; PACIFIC ISLANDER; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRAVEL; UNITED STATES;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DRUG RESISTANCE, BACTERIAL; ETHNIC GROUPS; FEMALE; FLUOROQUINOLONES; GONORRHEA; HAWAII; HUMANS; LABORATORIES, HOSPITAL; MALE; MEDICAL RECORDS; MIDDLE AGED; NEISSERIA GONORRHOEAE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 9344233874     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000145846.45781.a4     Document Type: Review

References (14)

1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Trans Infect 1999; 75:3-17.
2. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998; 47(no. RR-1).
3. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antimicrobial resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region. 1999. Commun Dis Intell 2000; 24:269-271.
4. Schwarcz SK, Zenilman JM, Schnell D, et al. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. JAMA 1990; 264:1413-1417.
5. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2000 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report - 2000. Atlanta: US Department of Health and Human Services; October 2001.
6. Knapp JS, Neal SW, Parekh MC, Ohye R, Higa H, Rice RJ. Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Honolulu, Hawaii. Antimicrob Agents Chemother 1994; 38:2200-2203.
7. Trees DL, Sandul AL, Neal SW, et al. Molecular epidemiology of Neisseria gonorrhoeae exhibiting decreased susceptibility and resistance to ciprofloxacin in Hawaii. 1991-1999. Sex Transm Dis 2001; 28:309-314.
8. Trees DL, Sandul AL, Peto-Mesola V, et al. Alterations within the quinolone resistance-determining regions of GyrA and ParC of Neisseria gonorrhoeae isolated in the Far East and the United States. Int J Antimicrob Agents 1999; 12:325-332.
9. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Surveillance of antimicrobial susceptibility of Neisseria gonorrhoeae in the WHO Western Pacific Region 1992-4. Genitourin Med 1997; 73:355-361.
10. Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae - Colorado and Washington, 1995. MMWR Morb Mortal Wkly Rep 1995; 44:761-764.
11. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae - Hawaii and California, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:1041-1044.
12. Centers for Disease Control and Prevention. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999. MMWR Morb Mortal Wkly Rep 2000; 49:833-837.
13. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men-United States, 2003, and Revised Recommendations for Gonorrhea Treatment, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:335-338.
14. Boslego JW, Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 1987; 317: 272-278.